27.01.2015 Views

REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...

REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...

REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>REP11</strong>/<strong>PR</strong> 14<br />

128. Some delegations pointed out that MRLs could always be revised when new data became available and therefore both<br />

alternatives could be considered provided the conditions for revision or revocation of MRLs were clearly specified on a scientific<br />

basis.<br />

129. The Delegation of Australia indicated that in CRD 24 they had proposed an approach that would allow existing CXLs to be<br />

retained without a residue re-evaluation provided a toxicological assessment by JM<strong>PR</strong> does not raise any health concerns; dietary<br />

exposure estimates are below the ADI and the ARfD; and there is evidence of GAP relevant to existing CXLs. The Delegation also<br />

highlighted the role of the priorities working group to give advance notice of the periodic re-evaluation and the need for providing<br />

relevant data in a timely manner.<br />

130. The Committee considered whether the rest of the document could be reviewed at the current session. However several<br />

delegations pointed out that it would be preferable to resolve the issue of the periodic review before reviewing the text as a whole to<br />

ensure consistency with the Working Principles for Risk Analysis.<br />

131. Following further consultations between interested countries, the Committee considered a new proposal put forward by Brazil<br />

in CRD 28 as a basis for future discussion of the periodic review, as follows:<br />

1) When a CXL is not supported by the manufacturers: the interested member countries can support the MRL submitting the<br />

GAP or to provide new residue data and GAP to JM<strong>PR</strong> for a new recommendation.<br />

2) When the whole compound is not supported by the manufacturers: the interested member countries can support the reevaluation<br />

of the compound by submitting residue data and the monograph of toxicological data to JM<strong>PR</strong>. If the<br />

monograph is not enough, JM<strong>PR</strong> can request for additional data.<br />

The Delegation of Brazil also suggested to request JM<strong>PR</strong> advice on the minimum data requirement for submission in case the<br />

complete toxicological database was not available (e.g. summary data).<br />

132. The Committee agreed that reference to monographs referred to national monographs of toxicological data for submission to<br />

JM<strong>PR</strong>.<br />

133. The Committee also agreed to use these proposals as a basis for further work, with the understanding that more detailed<br />

discussion would be needed to develop specific recommendations.<br />

134. The Observer from CropLife expressed the view that both recommendations seemed to conflict with JM<strong>PR</strong> responsibilities as<br />

they implied that JM<strong>PR</strong> would work with reduced data sets for the re-evaluation of MRLs; it was unclear how JM<strong>PR</strong> could update<br />

dietary risk assessment based only on GAP; JM<strong>PR</strong> can only make an informed decision when they have access to the full data set<br />

as currently required and to what extent they need to make use of these data has to be decided on a case-by- case. The Observer<br />

expressed concern that these changes may undermine the public confidence in Codex MRL, and generally supported retaining the<br />

principle of the current Periodic Review Procedure, with possible amendments for clarification purposes.<br />

135. The JM<strong>PR</strong> Secretariat recalled that data requirements for submission to JM<strong>PR</strong> were already defined and applied to any set of<br />

data submitted for assessment; when any information was missing, the submissions would be evaluated on a case by case basis;<br />

and only nationally approved GAP should be submitted to JM<strong>PR</strong>. Toxicological monographs would not need to be re-submitted, but<br />

only updated additional information, including toxicological data if available.<br />

136. The Committee discussed how to proceed further. Some delegations pointed out that the revision of the periodic review might<br />

affect other sections of the document and therefore the Risk Analysis Principles as a whole should also be revised concurrently,<br />

according to the initial mandate of the Committee. The Chair also recalled that the revision should be completed by 2013 in<br />

accordance with the Strategic Plan 2008-2013.<br />

Conclusion<br />

137. The Committee therefore agreed to re-convene the electronic working group chaired by Argentina and Brazil, working in<br />

English and Spanish, to develop proposals for the revision of the periodic review as a priority and, if feasible, to review the entire text<br />

of the Risk Analysis Principles, for consideration by the next session. It was also agreed that, if necessary, a physical working group<br />

chaired by Argentina and Brazil and working in English would be held prior to the next session in order to facilitate discussion in the<br />

plenary. The Delegation of Brazil emphasized the importance of effective participation and contribution of member countries in the<br />

work of the working group in order to advance work on the revision of the Risk Analysis Principles.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!